Myriad Genetics Inc (LTS:0K3W)
$ 2.9 -2.258 (-43.78%) Market Cap: 270.12 Mil Enterprise Value: 365.42 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 54/100

Q1 2026 Myriad Genetics Inc Earnings Call Transcript

May 05, 2026 / 08:30PM GMT
Release Date Price: $4.88 (-3.37%)
Operator

Good day and thank you for standing by. Welcome to the Myriad Genetics first quarter 2026 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded.

Now it's my pleasure to hand the conference over to the Senior Vice President of Investor Relations, Matt Scalo. Please proceed.

Matthew Scalo
Myriad Genetics Inc - Senior Vice President - Investor Relations

Good afternoon, and welcome to the Myriad Genetics first quarter 2026 earnings call. During the call, we will review the financial results we released today. And afterwards, we will host a Q&A session. Our earnings release was issued this afternoon on Form 8-K and can be found on our website at investor.myriad.com. I'm Matt Scalo, Senior Vice President of Investor Relations.

On the call with me today are Sam Raha, our President and Chief Executive Officer; Ben Wheeler, our Chief Financial Officer; and Brian Donnelly, our Chief Commercial Officer. Joining for Q&A will be Mark Verratti, our Chief Operating Officer. This call can be heard live

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot